167 related articles for article (PubMed ID: 17349622)
1. The calcitonin gene-related peptide (CGRP) receptor antagonist BIBN4096BS reduces neurogenic increases in dural blood flow.
Tröltzsch M; Denekas T; Messlinger K
Eur J Pharmacol; 2007 May; 562(1-2):103-10. PubMed ID: 17349622
[TBL] [Abstract][Full Text] [Related]
2. Stimulation of rat cranial dura mater with potassium chloride causes CGRP release into the cerebrospinal fluid and increases medullary blood flow.
Dux M; Will C; Eberhardt M; Fischer MJM; Messlinger K
Neuropeptides; 2017 Aug; 64():61-68. PubMed ID: 28202186
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of stimulated meningeal blood flow by a calcitonin gene-related peptide binding mirror-image RNA oligonucleotide.
Denekas T; Tröltzsch M; Vater A; Klussmann S; Messlinger K
Br J Pharmacol; 2006 Jun; 148(4):536-43. PubMed ID: 16633354
[TBL] [Abstract][Full Text] [Related]
4. The nonpeptide calcitonin gene-related peptide receptor antagonist BIBN4096BS lowers the activity of neurons with meningeal input in the rat spinal trigeminal nucleus.
Fischer MJ; Koulchitsky S; Messlinger K
J Neurosci; 2005 Jun; 25(25):5877-83. PubMed ID: 15976076
[TBL] [Abstract][Full Text] [Related]
5. Effects of the calcitonin gene-related peptide (CGRP) receptor antagonist BIBN4096BS on alpha-CGRP-induced regional haemodynamic changes in anaesthetised rats.
Arulmani U; Schuijt MP; Heiligers JP; Willems EW; Villalón CM; Saxena PR
Basic Clin Pharmacol Toxicol; 2004 Jun; 94(6):291-7. PubMed ID: 15228501
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of the non-peptide CGRP receptor antagonist BIBN4096BS in blocking CGRP-induced dilations in human and bovine cerebral arteries: potential implications in acute migraine treatment.
Moreno MJ; Abounader R; Hébert E; Doods H; Hamel E
Neuropharmacology; 2002 Mar; 42(4):568-76. PubMed ID: 11955527
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of BIBN4096BS on cephalic vasodilatation induced by CGRP or transcranial electrical stimulation in the rat.
Petersen KA; Birk S; Doods H; Edvinsson L; Olesen J
Br J Pharmacol; 2004 Nov; 143(6):697-704. PubMed ID: 15504760
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist.
Doods H; Hallermayer G; Wu D; Entzeroth M; Rudolf K; Engel W; Eberlein W
Br J Pharmacol; 2000 Feb; 129(3):420-3. PubMed ID: 10711339
[TBL] [Abstract][Full Text] [Related]
9. Effects of BIBN4096BS on cardiac output distribution and on CGRP-induced carotid haemodynamic responses in the pig.
Kapoor K; Arulmani U; Heiligers JP; Willems EW; Doods H; Villalón CM; Saxena PR
Eur J Pharmacol; 2003 Aug; 475(1-3):69-77. PubMed ID: 12954361
[TBL] [Abstract][Full Text] [Related]
10. Endovanilloids are potential activators of the trigeminovascular nocisensor complex.
Dux M; Deák É; Tassi N; Sántha P; Jancsó G
J Headache Pain; 2016; 17():53. PubMed ID: 27189587
[TBL] [Abstract][Full Text] [Related]
11. Binding properties of the novel, non-peptide CGRP receptor antagonist radioligand, [(3)H]BIBN4096BS.
Schindler M; Doods HN
Eur J Pharmacol; 2002 May; 442(3):187-93. PubMed ID: 12065071
[TBL] [Abstract][Full Text] [Related]
12. Calcitonin gene-related peptide (CGRP) modulates nociceptive trigeminovascular transmission in the cat.
Storer RJ; Akerman S; Goadsby PJ
Br J Pharmacol; 2004 Aug; 142(7):1171-81. PubMed ID: 15237097
[TBL] [Abstract][Full Text] [Related]
13. Interaction of calcitonin gene-related peptide, nitric oxide and histamine release in neurogenic blood flow and afferent activation in the rat cranial dura mater.
Schwenger N; Dux M; de Col R; Carr R; Messlinger K
Cephalalgia; 2007 Jun; 27(6):481-91. PubMed ID: 17441973
[TBL] [Abstract][Full Text] [Related]
14. Nitric oxide releases calcitonin-gene-related peptide from rat dura mater encephali promoting increases in meningeal blood flow.
Strecker T; Dux M; Messlinger K
J Vasc Res; 2002; 39(6):489-96. PubMed ID: 12566974
[TBL] [Abstract][Full Text] [Related]
15. Development and potential of non-peptide antagonists for calcitonin-gene-related peptide (CGRP) receptors: evidence for CGRP receptor heterogeneity.
Wu D; Doods H; Arndt K; Schindler M
Biochem Soc Trans; 2002 Aug; 30(4):468-73. PubMed ID: 12196117
[TBL] [Abstract][Full Text] [Related]
16. Involvement of nitric oxide in the modulation of dural arterial blood flow in the rat.
Messlinger K; Suzuki A; Pawlak M; Zehnter A; Schmidt RF
Br J Pharmacol; 2000 Apr; 129(7):1397-404. PubMed ID: 10742295
[TBL] [Abstract][Full Text] [Related]
17. Increase of meningeal blood flow after electrical stimulation of rat dura mater encephali: mediation by calcitonin gene-related peptide.
Kurosawa M; Messlinger K; Pawlak M; Schmidt RF
Br J Pharmacol; 1995 Apr; 114(7):1397-402. PubMed ID: 7606344
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of BIBN4096BS, CGRP(8-37), a CGRP antibody and an RNA-Spiegelmer on CGRP induced vasodilatation in the perfused and non-perfused rat middle cerebral artery.
Edvinsson L; Nilsson E; Jansen-Olesen I
Br J Pharmacol; 2007 Mar; 150(5):633-40. PubMed ID: 17245362
[TBL] [Abstract][Full Text] [Related]
19. The in vivo effect of adrenomedullin on rat dural and pial arteries.
Juhl L; Petersen KA; Larsen EH; Jansen-Olesen I; Olesen J
Eur J Pharmacol; 2006 May; 538(1-3):101-7. PubMed ID: 16643888
[TBL] [Abstract][Full Text] [Related]
20. Investigation of the species selectivity of a nonpeptide CGRP receptor antagonist using a novel pharmacodynamic assay.
Hershey JC; Corcoran HA; Baskin EP; Salvatore CA; Mosser S; Williams TM; Koblan KS; Hargreaves RJ; Kane SA
Regul Pept; 2005 Apr; 127(1-3):71-7. PubMed ID: 15680472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
